A double-blind trial of Lactobacillus paracasei strain KW3110 administration for immunomodulation in patients with pollen allergy

Allergology International

Volumn 54, Issue 1, 2005, Pages 143-149

  Fujiwara, Daisuke ^a   Wakabayashi, Hideyuki ^a   Watanabe, Hiroyuki ^a   Nishida, Satoshi ^b   Iino, Hisakazu ^c  

^a KIRIN BREWERY CO LTD   (Japan)

^b Shizukuishi Iwate Gun   (Japan)

^c SHOWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

ECP; Lactobacillus paracasei strain KW3110; Th1; Th2; Yogurt

Indexed keywords

CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; OVALBUMIN; YOGHURT;

ADULT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DOUBLE BLIND PROCEDURE; EOSINOPHIL; FEMALE; HUMAN; IMMUNOMODULATION; LACTIC ACID BACTERIUM; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS PARACASEI; LACTOBACILLUS PARACASEI STRAIN KW3110; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; POLLEN ALLERGY; PRIORITY JOURNAL; SEASON; TH1 CELL; TH2 CELL;

EID: 17044431564     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.2332/allergolint.54.143     Document Type: Article

References (16)

1. Fujiwara D, Inoue S, Wakabayashi H et al. The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int. Arch. Allergy Immunol. 2004;135:205-215.
2. Wheeler JG, Shema SJ, Bogle ML et al. Immune and clinical impact of Lactobacillus acidophilus on asthma. Ann. Allergy Asthmma Immunol. 1997;79:229-233.
3. Pessi T, Sutas Y, Hurme M et al. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy 2000;30:1804-1808.
4. Kirjavainen PV, Arvola T, Salminen SJ et al. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 2002;51:51-55.
5. Kalliomaki M, Salminen S, Arvilommi H et al. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001;357:1076-1079.
6. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989;299:1259-1260.
7. Yazdanbakhsh M, Kremsner PG, Ree RV. Allergy, parasites, and the hygiene hypothesis. Science 2002;296:490-494.
8. Fujiwara H, Masuda M, Kubo N et al. Seasonal changes of laboratory data in patients with Japanese cedar pollinosis. Jpn. J. Clin. Pathol. 1997;45:487-492.
9. Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma. N. Engl. J. Med. 1990;323:1033-1039.
10. Moverare R, Elfman L, Bjornsson E et al. Cytokine production by peripheral blood mononuclear cells following birch-pollen immunotherapy. Immunol. Lett. 2000;73:51-56.
11. Sheih YH, Chiang BL, Wang LH et al. Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J. Am. Coll. Nutr. 2001;20:149-156.
12. Hatakka K, Martio J, Korpela M et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis-a pilot study. Scand. J. Rheumatol. 2003;32:211-215.
13. Wullt M, Hagslatt ML, Odenholt I. Lactobacillus plantarum 299 v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial. Scand. J. Infect. Dis. 2003;356:365-367.
14. Kraehenbuhl JP, Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2001;2:361-367.
15. Majamaa H, Isolauri E. Probiotics: A novel approach in the management of food allergy. J. Allergy Clin. Immunol. 1997;99:179-185.
16. Helin T, Haahtela S, Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birth-pollen allergy: a placebo-controlled double-blind study. Allergy 2002;57:243-246.